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Abstract 
A library of novel high molecular weight polymers based on the natural carotenoid astaxanthin (ATX) 
has been successfully synthesized. ATX is a powerful antioxidant, known for its various therapeutic 
properties including anti-inflammatory and antimicrobial activities. It is a xanthophyll with a 
symmetric chemical structure bearing two hydroxyl groups. Thus, its copolymerization with various 
diacids resulted in “polyactive” polyesters with varying chemico-physio-mechanico properties (e.g., 
Storage moduli range: 125-1300 MPa and wetting angles of 40-110°). The potential of pATX as an 
antimicrobial agent was demonstrated in vitro against clinically relevant bacteria (Staphylococcus 
aureus MRSA252 and MSSA476; S. epidermidis 1457) showing significant reduction of both bacterial 
growth and biofilm formation. Lastly, we establish using pATX films in vivo had no adverse effect in 
direct contact with open wounds, or on the complete physiological process of whole animal wound 
healing.   
 
Introduction 
Few polymeric systems are based on monomers that are both naturally occurring and are inherently 
therapeutic. Though polymers derived from natural metabolites such as lactic acid,1,2 or amino acids 
such as tyrosine3-6 are well established in the field of implantable medical devices, these materials 
are designed to be benign at best with regards to any tissue interactions. Therapeutic polymers, or 
“polyactives”, are polymer systems in which a pharmacological molecule is incorporated onto the 
polymer chain either as an attached pendant group, or as a structural part of the formed polymer 
backbone. This allows for a localized and sustained bioactive release with negligible systemic 
exposure.7 In a pendant chain model, the polymer backbone generally acts as carrier, and does not 
participate directly as a therapeutic entity.8 When the bioactive molecule is a monomeric 
constituent of the polymer backbone, a biocompatible, biologically inert co-monomer (linker) is 
usually required.7,8 Examples of the latter include various types of therapeutic inclusions, including 
anti-inflammatory drugs such as salicylic acid (aspirin)-derived poly(anhydride-esters),9,10 
antioxidants, antiseptics, antibiotics and analgesics.7 Curcumin-derived biodegradable polymers are 
a unique example of a polyactive where the polymer backbone is made from curcumin units.11,12 
Astaxanthin (3,3'-dihydroxy-β,βcarotene-4,4'-dione) is a common  nutritional, organic red pigment 
(Figure 1). ATX possess the empiric formula of (C40H52O4) and is produced by microorganisms such 
as fungi and algae, and is also found in marine animals (e.g. salmon, crustaceans) providing them 
with their distinct reddish colour.13,14 
 
ATX has been extensively researched in the medical field due to its potent bioactivity. Recent 
findings include therapeutic properties, anticancer, antidiabetic, and anti-inflammatory activities, 
gastro-, hepato-, neuro- and cardiovascular protective effects, as well as other activities.13,14 
Moreover, ATX has been shown in various assays to significantly inhibit the growth of both Gram-
positive and negative pathogens.15,16 Despite the potential and promising applications of ATX in 
human health and nutrition, little effort has been directed towards using it as a polymeric prodrug. 
Currently, the only existing evidence is the recently described synthesis of low to medium molecular 
weight poly(lactides) where ATX was used as a bifunctional initiator in the ring opening 
polymerization process.17 Since ATX is a highly lipophilic, low molecular weight compound,18,19 
chemical modifications through its available free hydroxyl groups improve its parenteral 
viability.19,20 Cardax™ is a synthetically sourced ATX modified with disodium disuccinate,19,20 or 
with the amino acid lysine21,22 to increase water solubility while maintaining therapeutic efficacy. In 
this work, we synthesized a library of new polymeric biomaterials based on ATX as a monomeric 
constituent – polyastaxanthins (pATX). These novel polymers have wide-ranging physical properties 
due to the use of varying dicarboxylic acid co-monomer. We subsequently established that pATXs 
have significant antimicrobial activity against the clinically-associated infectious pathogens 
Staphylococcus epidermidis 1457, methicillin susceptible Staphylococcus aureus MSSA476 and the 
methicillin resistant S. aureus MRSA252.23 In vivo compliance was tested using a mouse dorsal 
wound model, in which the polymer was placed in direct contact with open wounds and was found 
to allow the unfolding of a normal process of wound healing without adverse effects. These results 
demonstrate the potential of pATX as a safe clinically-relevant antimicrobial agent. 
 
Experimental 
Materials and general methods 
The HPLC grade organic solvents and compounds were purchased from Sigma-Aldrich Chemicals 
(Rehovot, Israel). Astaxanthin (ATX), was purchased from 3B Pharmachem International Ltd. (China). 
NMR spectra were recorded on a Varian NMRS 300 or 500 MHz instrument. 1H NMR chemical shifts 
are reported in ppm relative to the solvent’s residual 1H signal. 13C NMR spectra were recorded at 
125 MHz. Chemical shifts were expressed in δ (ppm) and coupling constants (J) in hertz units. Mn, 
Mw and polydispersity (Mw/Mn) were determent using Size exclusion chromatography (SEC) 
analysis in THF on a VE 7510, GPC (Malvern, Viscotek) at 35°C. Polymers were dissolved in THF 
(5mg/ml) for 24 h and the results are reported relative to polystyrene standards. Glass transition 
temperature (Tg) and storage moduli (E’) were determined on solvent cast films using a dynamic 
mechanical analysis (DMA) and a TA Q800 DMA operated at -30°C to 120°C at a heating rate of 5°C 
min-1 using a 1 Hz frequency. The static contact angle was measured according to the sessile drop 
method using a contact angle analyzer (OCA 20, Dataphysics Instruments, Germany). Contact angles 
were measured using 5 µL water drops of deionized and ultra-filtered water (0.2 µm filter). The 
contact angle was measured using a video-based software (SCA 20, Dataphysics Instruments GmbH, 
Germany). Results are expressed as the mean of four measurements with a standard error of mean. 
 
Polyastaxanthin synthesis 
The different polymers were synthesized in a 50 ml amber scintillation vial under inert 
environment.1.67 mmol different diacid derivatives, 0.837 mmol DPTS, and 1.67 mmol ATX were 
dissolved in 8 ml dry DCM. Then, 5.026 mmol DIC was added dropwise over a 3 h period. The 
reaction was stirred for 24 h at room temperature. Reaction solution was then precipitated in IPA 
and the precipitated product was collected and dried for 30 min followed by second precipitation in 
EtOH then collected and vacuum-dried till further use.  
 
Polymer film preparation 
Solvent cast films of the polymer were prepared by dissolving the dried polymer in THF anhydrous 
(10% w/v). After complete dissolution, they were cast into a PTFE mold in a chemical hood for 
solvent evaporation then placed under vacuum for complete solvent evaporation. 6 
 
Antibacterial assays 
In vitro toxicity evaluation   
Experiment was done in a direct contact model. L6 skeletal myocytes were grown and differentiated 
to myotubes cells in α-MEM medium supplemented with 2% (v/v) FCS. The cells were seeded in 
triplicates in 6 well plates. Polymer films (poly(ATX-co-dodecanedioic acid); poly(ATX-co-
poly(ethylene glycol) bis(carboxymethyl) ether), Avg. Mn 250 and poly(ATX-co-malonic acid))  
weighing approximately 50 mg were first washed in ethanol for sterilization, then washed twice with 
growing medium and placed in the wells. Cells were incubated for 48 h with the different polymers. 
Glucose oxidase (GO) was used as a negative control (100 mU/ml of GO) added 1.15h before the 
termination of the experiment. Upon completion of incubation, a standard MTT test was 
performed.24 
 
pATX-coated microtitre plates 
96-well polypropylene plates were coated by dispensing 150 µl of polymeric solution (10% w/v in 
THF) into the wells.25 The plates were left in the dark and the solvent was evaporated at room 
temperature in a fume hood. The following pATX and controls were used as coatings – ATX 
monomer; poly(ATX-co-sebacic acid); poly(ATX-co-hexadeceandioic acid); poly(ATX-co-poly(ethylene 
glycol) bis(carboxymethyl) ether), Avg. Mn 250; poly(ATX-co-poly(ethylene glycol) 
bis(carboxymethyl) ether), Avg. Mn 2000; poly(ATX-co-dodecanedioic acid); poly(ATX-co-pimelic 
acid); poly(ATX-co-malonic acid); Sebacic acid (SA); poly(ethylene glycol) bis(carboxymethyl) ether 
Avg. Mn 250 (PEG 250). Each compound coated 3 wells per 2 rows and the last 2 rows were left 
blank as control. 
 
Bacterial strains 
Staphylococcus aureus MRSA252, S. aureus MSSA476 and S. epidermidis 1457 were streaked from 
frozen stocks onto Columbia agar supplemented with 5 % horse blood (Oxoid, Thermo Fisher 
Scientific, Loughborough, UK), then incubated overnight at 37°C and used in subsequent 
experiments. 
 
Bacterial growth and biofilm analysis 
To determine the effect of the pATX-coatings on S. aureus and S. epidermidis growth and biofilm 
formation the previously described semi-quantitative adherence assay 26,27 was used and modified as 
follows. 3 ml Trypticase Soy Broth (TSB; Becton Dickinson, Cockeysville, USA) was inoculated with a 
colony from an overnight plate. Pre-cultures were grown at 37°C with shaking to mid-exponential 
phase (2-3 h), and then used to inoculate fresh TSB to a starting OD600 of 0.01 (approx. 105 CFU/ml). 
200 µl aliquots of the suspension were then inoculated into the coated test wells (6 wells per 
compound) and control wells (uncoated) of the 96 well plate. The plate was then incubated in a 
FLUOstar OPTIMA microplate reader (BMG, Offenburg, Germany) at 37°C, and the optical density of 
each well was measured at 600 nm every hour over a 24 h period. Inhibition of growth by the pATX- 
removed and washed with phosphate buffered saline, pH 7.4 (PBS) and air dried. All plates were 
stained with 150 µl crystal violet solution (Sigma-Aldrich, Gillingham, UK) for 10 min and then excess 
solution washed off with water. The plate was then left to air-dry before the bound, crystal violet 
was solubilized by addition of 95 % ethanol at 150 µl. Optical density was measured as absorbance 
at 570 nm using a FLUOstar OPTIMA microplate reader and biofilm positive was defined as OD570 
above 0.2.27 All S. aureus and S. epidermidis isolates were tested in triplicate in four independent 
experiments. Each microtitre plate also consisted of negative controls (wells without bacterial 
inoculation). Data was analyzed using unpaired t-tests or one-way ANOVA, and the level of 
significance set at p < 0.05. 
 
Animals 
Female C57BL/6 mice (6-8 weeks old) were purchased from Harlan, Israel. Animal experiments were 
approved by Institutional Animal Care and Use Committee (BGU).  
 
In vivo evaluation using wound closure model 
In vivo dorsal wound mouse model was performed as described previously.28 Briefly, C57BL/6 mice 
were anesthetized using ketamine/xylazine. Fur was removed using an electric razor and spine 
midline was marked with a surgical pen. Dorsal skin was folded and raised to form a 2-layer skin fold. 
With the animal in a lateral position, a 5-mm sterile biopsy punch was applied to remove a uniform 
section out of the two layers, thus forming two symmetrical full-thickness excisional wounds. Each 
polymer-dressed wound was therefore accompanied by its adjacent control untreated wound in the 
same animal. Polymer disks were soaked in sterile PBS solution 30 min prior to application to assure 
proper adherence to the wound. Wounds were then wrapped in sterile gauze for 48 h and presence 
of polymer disks was visually confirmed at the time of bandage removal. Wound area was 
photographed at 48 h intervals and calculated using Fiji image software analysis. Wound closure was 
defined as wound area < 5 % of day-0 area. 
 
Results and discussion 
Synthesis and chemical/physical characterization of p(ATX) 
As demonstrated by Stupp et al.29, carbodiimide-mediated coupling of diols and diacids is an efficient 
method for the synthesis of polyesters under mild conditions. The application of Stupp’s technique 
towards high molecular weight polyesters with varying properties have been previously 
demonstrated on tyrosine derived polyarylates.30,3 Using this method, a library of pATX polymers 
were synthesized (Scheme 1) and resulted with a high molecular weight bioactive polymers with 
good yields. As shown in Table 1, a variety of poly(ATX)'s were synthesized using this methodology 
with high yield (70-95%), and as measured using GPC high molecular weight (up to 130 kDa), and 
relatively low polydispersity (1.2-1.9). Low PDI values in carbodiimide-mediated step growth 
polymerizations have been reported.31 The effect of hydrophobic diacids lengths on the physical 
properties of each polymer as shown through the listed glass transition temperature (Tg) and 
storage moduli (Table 1) were measured using DMA. Wetting angle measurements (mean of four 
measurements ± SD) indicated that these polymers were hydrophobic (Table 1). Optimization of the 
synthesis process was conducted to determine required time and type of catalyst that would in an 
efficient process.29 We compared between DMAP, the known catalyst for this kind of esterification32 
and DPTS, the catalyst used by Stupp et al. 29  As shown in Figure S1, the use of DPTS during 24 h 
resulted in superior higher Mw. We then built our library of polymers by reacting ATX with 
differentalkylic diacids (Scheme 1). Polyethylene glycol (PEG) was used as the hydrophilic diacids co-
monomer, and was used tosynthesized a small library of p(ATX) with different Mw of PEG as co-
monomer. The Mw of the PEG used ranged from 250 to 2000 (Scheme 2).The synthesis process of 
the PEG-based polymers was the same as with the hydrophobic diacids. Changes in the Mw of the 
PEG block used resulted in changes in the physical properties of the polymers, as depicted by the 
changes in the glass transition temperature (Tg) and storage moduli (Table 2). As expected, the 
wetting angle results indicate that the polymers were hydrophilic. In accordance with work by 
Bourke SL and Kohn J,3 a range of properties can be reached as function of the diacid used. We 
observed mechanical properties that span from elastomer-like properties (highly PEGylated 
polymers), to stiff polymers (high alkane chains, or low PEGylation), to brittle materials (low alkane 
chains). Curcumin, in similarity to ATX, is a naturally occurring antioxidant, which can be applied as a 
diol-monomer in the synthesis of condensation polymers. Also, as pATX, curcumin-derived polymers 
exhibited varying physical properties with substantial bioactivity, specifically as anti-cancerous 
agents.11-12,33 All chemical structures were analysed by 1H NMR, 13C NMR and two-dimensional (2D) 
NMR spectroscopy, which provided detailed information about the unique structure of each polymer 
(supp. material). NMR spectra analysis of Poly(ATX-co-dodecanedioic acid) (Figure S10) is an example 
for the unique structure of these polymers. Two repeating units are supposed to exist in the 
polymers, one is the ATX and the other is the diacid derivative. The peaks at δ 1.94-2.13 ppm were 
assigned to hydrogen atoms 1,34 (CH2-group) in the ATX unit while those in the diacid derivative 
unit at  δ 2.43, 1.69, 1.24-1.41 ppm were assigned to hydrogen atoms (47,56), (48, 55), (49-51) 
respectively. 
 
The peaks at δ 5.53 ppm were assigned to hydrogen atoms 2,35 (CH-group) in the ATX unit and the 
peaks at δ 6.05-6.74 ppm were assigned to hydrogen atoms 
12,13,15,17,18,20,22,23,24,26,27,28,30,31 (CH-group) at the ATX's polyene fragment. The peaks at δ 
1.22, 1.24-1.41 ppm were assigned to hydrogen atoms 7,8,41,42 (CH3-group) in the ATX unit. The 
peaks at δ 1.90 ppm were assigned to hydrogen atoms 9,38 (CH3-group) in the ATX unit and the 
peaks at δ 1.94-2.13 ppm were assigned to hydrogen atoms 16,21,44,45 (CH3-group) in the ATX's 
polyene fragment unit. The peaks in the 13C NMR spectrum of Poly(ATX-co-dodecanedioic acid) 
were also divided to the ATX unit and to the diacid unit. During the structure analysis we followed 
mainly after significant carbons in the ATX unit such as 2,35 and their peak at δ 70.97 ppm, carbons 
3,36 and their peaks at δ 194.25 ppm and carbons 1,34 and their peaks at δ 42.70 ppm. In the diacid 
unit we followed mainly after carbons 40,57 and their peak at δ 173.29 ppm. The chemical shift of 
these carbons points on the formation of the ester bond. All other carbons were found and their 
chemical shifts were adjusted to their place in the repeating units (Figure S10). These results have 
been validated with 2D NMR spectroscopy such as COSY and HSQC (supp. Info.). 
 
Biological activity 
Antibacterial activity 
Synthesis of antimicrobial polymers have been describes by Carbone-Howell et al.,34 where 
inherently antimicrobial essential oils were synthesized into biodegradable poly(anhydride-esters). 
The hydrolysed polymer products exhibited antimicrobial activity against gram negative and gram 
positive bacteria. Our main aim was to synthesize ATX as polymeric antibacterial agents. A 
preliminary in vitro toxicity experiment was conducted using L6 cells to evaluate the impact of three 
polymers. We used in this assay two hydrophobic polymers that differ in their length of the co-
monomers: poly(ATX-co-dodecanedioic acid); poly(ATX-co-malonic acid) and one hydrophilic 
polymer: Poly(ATX-co-PEG250). The results show a mild toxicity (more than 70% cell survival) after 
incubation for 48 h (Figure S2). Results indicated that after 48 h, more than 70% of the cells survived. 
In our effort to make pATX more water soluble and by doing so the polymers will be more potent, 
we used different PEGs as co-monomers. PEG is widely used in biomaterial synthesis, as it is known 
to reduce protein adsorption on polymers surfaces and increase polymer biodegradation rates.35-37 
To determine the antimicrobial properties of p(ATX), in vitro growth assays were conducted using 
the clinically relevant bacteria S. epidermidis 1457, S. aureus MSSA476 and S. aureus MRSA252, and 
96 well-plates coated with different polymers with varying structures (hydrophilic and hydrophobic). 
Due to the complexity of this assay, we chose only four different polymers that represent the edges 
of each group-hydrophobic and hydrophilic. Figure 2 depicts bacterial average growth rate at the 
24th hour for each polymer over no pATX control. As shown, poly(ATX-co-PEG2000), poly(ATX-co-
malonic acid), Poly(ATX-co-dodecanedioic acid) and Poly(ATX-co-PEG250) were significantly resistant 
against all strains (p ≤ 0.001). Poly(ATX-co-malonic acid) and Poly(ATX-co-PEG2000) exhibited 
bacteriostatic effect on all staphylococcal strains tested, whilst Poly(ATX-co-PEG250) and Poly(ATX-
co-dodecanedioic acid) had a bactericidal effect against the tested staphylococci. Another 
encouraging result from this current study was the observation that different polymers showed 
antibacterial activity against a methicillin-resistant S. aureus strain. With the advent of antibiotic 
resistant bacteria and the associated risk of critically limiting surgeries, joint replacements, organ 
transplantation, cancer chemotherapies and other important medical procedures, there is great 
motivation to develop new compounds that are active against such bacteria. 
 
As reviewed by Ivanova et al., current antimicrobial surface coatings tend to exhibit signs of 
deficiencies such as lack in long-term antibacterial activity, insufficient concentration of released 
agents, etc..38 Thus, the pATX tested clearly show potential as antimicrobial coatings against 
staphylococci and importantly MRSA. Infections are commonly associated with implantable medical 
devices due to the ability of bacteria such as staphylococci adhere to the implant surface, resulting in 
significant patient morbidity and mortality.39 Once attached bacteria have the ability to form 
biofilms, which can then lead to persistent infections and resistant to conventional antimicrobial 
treatments.39 The ability of the bacteria to form a biofilm in the presence of the pATX coatings was 
determined using a semi-quantitative biofilm assay and culturing for 24 h. As shown in Figure 3, 
Poly(ATX-co-PEG250), Poly(ATX-co-dodecanedioic acid) and Poly(ATX-co-PEG2000) inhibit the 
bacteria from forming biofilms on the surfaces in comparison to the control, while poly(ATX-co-
malonic acid) had no effect on biofilm formation. The amount of biofilm formed in the control wells 
was significantly higher to the pATX wells (p ≤ 0.001). To date, little is known about the mechanism 
for antimicrobial activity of ATX.15,16 Figure 3 illustrates significant inhibition of bacteria growth for all 
the ATX-based polymers tested, yet the differences in activity between the polymers and the modus 
operandi are still unknown.  
 
In vivo evaluation of pATX  
Importantly, such compounds must accommodate physiological processes related to the mentioned 
above procedures, most importantly, wound closure and tissue repair. Normal wound healing is a 
complex, concerted process involving parenchymal cells, extracellular matrix and soluble mediators, 
such as growth factors and cytokines, and is highly susceptible to local interferences. Our study 
directly challenged the polymers in this regard in a highly stringent model for physiological wound 
healing. Disks made from different polymers were tested in vivo to determine their effect on 
exposure to live tissue. Uniformly generated open wounds on the dorsum of mice were directly 
covered in full contact with the disks, and their effect on the delicate process of normal wound 
healing was compared to same-animal bare wounds. As shown in Figure 4, polyastaxanthin exhibited 
no effect on the normal wound closure process, exhibiting a consistent colour change dynamic and 
no macroscopic differences in tissue appearance. As reviewed by Orgill et al., todays clinical wound 
healing implants are facing quite a few problems such as mechanical mismatch with the body and 
most importantly inability to postpone or eliminate infections.40 The development of polymeric 
material with varying physical properties that are made from a naturally-derived monomer that is 
inherently antimicrobial could have with further development significant impact of such devices. 
 
Conclusions 
New astaxanthin-based bioactive polymers have been synthesized and characterized. By using 
different diacids as co-monomers, different physico-chemical-mechanical properties were obtained 
for each. The novel use of ATX as constituent in the polymer backbone has shown promising results 
as an antibacterial agent in vitro, specifically against MRSA. Along with its tissue-accommodating 
nontoxic nature, as established in the in vivo wound healing model, pATX has great potential as a 
useful material for coating of medical devices, as well as an antibacterial agent. More research is 
required to fully appreciate the spectrum of advantages and potential medical use of these novel 
polyactives. 
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Figures and Tables 
Table 1. Physical properties of p(ATX) Derivatives 
 
Table 2. Physical properties of poly[ATX-co-peg(biscarboxymethyl ether)] derivatives 
Polymer  Mw(Daltons) a Mn(Daltons) a PDI(Mw/Mn) a Tg (°C) b Storage Modulus (MPa) b  (Θ) 
Poly(ATX-co-
PEG250) 
88,200 45,800 1.92 44 1200 91.5 ± 3.1 
Poly(ATX-co-
PEG600) 
38,000 18,800 2.02 5.67 - 67.3 ± 1.3 
Poly(ATX-co-
PEG2000) 
59,700 15,000 3.98 -36.93  125 46.15 ± 7.1  
a) Mn, Mw and polydispersities (Mw/Mn) were determined by GPC. b) Tg (°C) and Storage Modulus (MPa) 
were determinate by DMA. 
  
Polymer  Mw(Daltons) Mn(Daltons) PDI(Mw/Mn)  Tg (°C)  Storage Modulus (MPa)       (Θ) 
poly(ATX-co-
malonic acid) 
57,200 40,100 1.42 - - - 
Poly(ATX-co-suberic 
acid)  
54,500 38,800 1.40 
 
53 1207 88.0 ± 1.7 
Poly(ATX-co-
Sebacic acid) 
130,400 78,500 1.66 48.4 1388 96.9 ± 1.1 
Poly(ATX-co-
dodecanedioic acid) 
114,800 64,600 1.77 39 365 109.0 ± 5.2 
Poly(ATX-co-
Hexadecanedioic 
acid) 
102,500 59,500 1.72 22 125 103.9 ± 2.9 
  
 
 
 
Figure 1. Astaxanthin structure 
 
 
Figure 2. Effect of pATX coatings on the average growth at 24h of S. epidermidis 1457, S. aureus 
MRSA252 and S. aureus MSSA476 isolates grown on (A) poly(ATX-co-malonic acid), (B) Poly(ATX-co-
PEG2000), (C) Poly(ATX-co-PEG250) and (D) Poly(ATX-co-dodecanedioic acid). Control black and 
pATX coating white; mean±SEM, * p ≤ 0.001. The effect of pATX copolymers on the growth of S. 
epidermidis 1457, S. aureus MRSA252 and S. aureus MSSA476 during a whole 24 h period is shown in 
Figure S11. 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Figure 3. Biofilm formation of S. epidermidis 1457, S. aureus MRSA252 and S. aureus MSSA476 on 
the different pATX surfaces. Black-control, white - Poly(ATX-co-PEG250), diagonal lines - Poly(ATX-
co-dodecanedioic acid) and stripes - Poly(ATX-co-PEG2000). Mean ± SEM, * p ≤ 0.001. 
 
 
Figure 4. Results demonstrating the effect of pATX polymers in the in vivo wound closure study. (A) 
Representative images at indicated time-points and (B) Pooled data from 2 separate experiments; 
wound closure defined as wound area <5% of day-0 area. Mean±SEM.  
A
  
B
  
Scheme 1. Synthesis of p(ATX) with different alkyl diacids 
 
 
Scheme 2. Synthesis of p(ATX) with different PEG 
 
